Boston Scientific is permanently laying off 106 employees at its Maple Grove location after taking one of its aortic valve systems off the market.
The company notified the state of Minnesota via WARN letter, as is required by law, that it will permanently lay off the workers starting on Jan. 19.
"Boston Scientific is voluntarily recalling its LOTUS Edge Aortic Valve System from the market and retiring the platform. As a result, the operational unit associated with this system will be closed and the employees will be laid off," the letter said.
On Tuesday, Boston Scientific launched a recall of the unused stock of LOTUS Edge Aortic Valve System due to "complexities" relating to the product delivery system.
"While we have been pleased with the benefits the LOTUS Edge valve has provided to patients, we have been increasingly challenged by the intricacies of the delivery system required to allow physicians to fully reposition and recapture the valve," Mike Mahoney, chairman and chief executive officer, Boston Scientific said in a statement.
"The complexity of the delivery system, manufacturing challenges, the continued need for further technical enhancements, and current market adoption rates led us to the difficult decision to stop investing in the Lotus Edge platform."
Instead, Boston Scientific says it'll focus its resources and efforts on its ACURATE neo2 Aortic Valve System, Sentinel Cerebral Embolic Protection System and other "high growth" areas.
Boston Scientific is based in Massachusetts and has two manufacturing centers in Minnesota, in Arden Hills and Maple Grove.